Oncolytics Biotech (ONCY) Prices 8M Shares at $4 (Halted)

February 20, 2013 9:03 AM EST Send to a Friend
Oncolytics Biotech, Inc. (NASDAQ: ONCY) announced today the pricing of an underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share.

Piper Jaffray & Co. and Wedbush PacGrow Life Sciences are acting as joint book-running managers for the offering in the U.S. and Paradigm Capital Inc. is acting as co-manager in the U.S. and book-running manager in Canada.

NOTE: Share halted


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings, Trading Halts

Related Entities

Piper Jaffray

Add Your Comment